Domenico Cerullo

Statistics

Publications

Citations

528

H-Index

Active since

2016

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

Luigi Sacco Hospital

University of Milan

Istituti di Ricovero e Cura a Carattere Scientifico

Ospedale Papa Giovanni XXIII

Domenico Cerullo is an author at Mario Negri Institute for Pharmacological Research specializing in renal pathophysiology, medicine, and renal disease.

ORCID

Publications per year

2016–2024

Publications

SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy

Paola Cassis, Monica Locatelli, Domenico Cerullo et al. · JCI Insight · 2018 · 173 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

<i>Sirt3</i> Deficiency Shortens Life Span and Impairs Cardiac Mitochondrial Function Rescued by <i>Opa1</i> Gene Transfer

Ariela Benigni, Paola Cassis, Sara Conti et al. · Antioxidants and Redox Signaling · 2019 · 107 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy

Paola Cassis, Monica Locatelli, Daniela Corna et al. · Kidney International · 2019 · 44 citations

Medicine, Endocrinology, Pharmacology +10

Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease

Cinzia Rota, Marina Morigi, Domenico Cerullo et al. · Stem Cell Research & Therapy · 2018 · 41 citations · Full text

Medicine, Cell Biology, Nephrology +17

Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the <scp>VEGF‐A</scp> /caveolin‐1/ <scp>PV</scp> ‐1 signaling pathway

Monica Locatelli, Sara Conti, Domenico Cerullo et al. · The Journal of Pathology · 2022 · 39 citations

Medicine, Endocrinology, Pharmacology +17

1–5 of 11